#Japan #Tokyo #BtoB Marketing #Medix #Sales Lab

Medix's Strategic Acquisition of Sales Lab

In a significant move to bolster its market position, Medix Corporation, headquartered in Chiyoda, Tokyo, made a decisive announcement on September 3, 2025, during its board meeting. The company has resolved to acquire shares in Sales Lab, based in Koto, Tokyo, thereby making it a subsidiary. This acquisition is a critical step in Medix's growth strategy, which emphasizes implementing an innovative concept known as "Beyond Advertising".

Rationale Behind the Acquisition

Medix aims to go beyond traditional online advertising, transitioning into new service domains. Their objective is to realize "Sellable" for customers and enhance retention. With this acquisition, Medix plans to expand into the BtoB sector, particularly in the realm of inside sales, supplementing their existing marketing services. The company recognizes that as the communication processes of BtoB enterprises evolve, there's an increasing demand for seamless integration among marketing, inside sales, and customer success. By welcoming Sales Lab into its group, Medix expects to accelerate its business growth significantly.

Inside sales refer to a sales methodology that leverages non-face-to-face communication tools, such as calls, emails, and web conferencing, to enhance engagement with customers. This technique aims to generate business opportunities and elevate purchase intent in a way that complements traditional marketing efforts.

Anticipated Benefits of the Acquisition

Medix believes that acquiring Sales Lab will yield substantial benefits, such as:

• - Strengthened Customer Relationships: By extending service offerings from advertising-promoted promotions to include inside sales strategies, Medix can cultivate deeper connections with its clients, enhancing overall customer experience.
• - Increased Business Opportunities: The synergy of promotional strategies and sales support will lead to enhanced opportunities for cross-selling and upselling, ultimately expanding client transactions.
• - Improved BtoB Marketing Accuracy: The data generated from inside sales can cycle back into advertising strategies, allowing for continuous refinement and improved engagement outcomes.
• - Growth of Recurring Revenue: Previously limited to spot promotions, the offering of continuous engagement through inside sales will bolster recurring revenue streams.

Sales Lab stands to gain from this partnership as well, enjoying advantages such as:

• - Differentiation from Competitors: By executing inside sales that align with Medix’s marketing strategies, Sales Lab can enhance its BPO strategy, setting itself apart from competitors.
• - Strengthened Client Relationships: Providing a seamless connection from marketing to sales improves relationship management and fosters loyalty among customers.
• - Increased Corporate Capability: The acquisition will provide Sales Lab with access to Medix’s rich marketing experience and knowledge, fostering employee development and the evolution of their existing services.

Conclusion and Future Outlook

Through this acquisition, Sales Lab is expected to become a consolidated subsidiary of Medix, with the integration poised to reflect in consolidated performance from the third quarter of fiscal 2026 onward. Although the anticipated impact on consolidated results is expected to be minor, Medix assures stakeholders that any significant developments will be communicated promptly.

About Medix

Headquarters: 1-105 Kanda Jinbocho, Chiyoda, Tokyo, 19F Jinbocho Mitsui Building
Business Overview: Comprehensive consulting services in digital marketing, internet advertising agency operations, web development, data analytics consulting, CRM consulting, and media support services.

For more information, visit Medix Corporate Website and IR Website.

Contact Information: Medix IR Department, Email: [email protected]